Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grignani

Showing results (511-520 of 688) with videos related to

Pageof 69
Sort By:
Nature Cell Biology|June 24, 2008
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesisCatherine Labbaye, Isabella Spinello, Maria Teresa Quaranta, et al.
Forensic Science International|February 27, 2018
Challenges in the identification of dead migrants in the Mediterranean: The case study of the Lampedusa shipwreck of October 3rd 2013Lara Olivieri, Debora Mazzarelli, Barbara Bertoglio, et al.
Blood|March 1, 1996
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminaseL Benedetti, F Grignani, B M Scicchitano, et al.
Haematologica|October 24, 2008
Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical siblingDaniela Lisini, Marco Zecca, Giovanna Giorgiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Blood|September 25, 1998
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion proteinC Nervi, F F Ferrara, M Fanelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase II study of imatinib in advanced chordomaSilvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.
Cells|February 10, 2021
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with NavitoclaxLeopoldo Sitia, Arianna Bonizzi, Serena Mazzucchelli, et al.
Journal of Clinical Medicine|January 26, 2019
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung CancerPaola Ulivi, Elisabetta Petracci, Giorgia Marisi, et al.
BMC Cancer|May 6, 2022
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumorMaria A Pantaleo, Michael C Heinrich, Antoine Italiano, et al.
Pageof 69

Showing results (511-520 of 688) with videos related to

Sort By:
Pageof 69
Nature Cell Biology|June 24, 2008
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesisCatherine Labbaye, Isabella Spinello, Maria Teresa Quaranta, et al.
Forensic Science International|February 27, 2018
Challenges in the identification of dead migrants in the Mediterranean: The case study of the Lampedusa shipwreck of October 3rd 2013Lara Olivieri, Debora Mazzarelli, Barbara Bertoglio, et al.
Blood|March 1, 1996
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminaseL Benedetti, F Grignani, B M Scicchitano, et al.
Haematologica|October 24, 2008
Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical siblingDaniela Lisini, Marco Zecca, Giovanna Giorgiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Blood|September 25, 1998
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion proteinC Nervi, F F Ferrara, M Fanelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase II study of imatinib in advanced chordomaSilvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.
Cells|February 10, 2021
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with NavitoclaxLeopoldo Sitia, Arianna Bonizzi, Serena Mazzucchelli, et al.
Journal of Clinical Medicine|January 26, 2019
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung CancerPaola Ulivi, Elisabetta Petracci, Giorgia Marisi, et al.
BMC Cancer|May 6, 2022
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumorMaria A Pantaleo, Michael C Heinrich, Antoine Italiano, et al.
Pageof 69